Department of Neurology, Institute of Neurosciences Kolkata, India.
Department of Medical Administration, Institute of Neurosciences Kolkata, India.
J Clin Neurosci. 2021 Nov;93:96-102. doi: 10.1016/j.jocn.2021.09.008. Epub 2021 Sep 15.
To describe the spectrum of hospitalized NeuroCOVID on admission in a tertiary neurology centre in Kolkata, the largest and most populated metropolitan city in Eastern India.
We retrospectively studied confirmed COVID-19 patients admitted with a neurological condition from 1st May 2020 to 30th January 2021. Neurological diagnoses and their temporal relationship to respiratory features along with clinicodemographic profile for such patients was ascertained.
228 patients were diagnosed with NeuroCOVID at our centre. Of the 162 included population (median age was 59 (50-70) and 62.3% (101) were male) and 73.5% were diagnosed with NeuroCovid before any respiratory or febrile features. 46 patients (28.8%) had a pre/co-existing neurological illness, and 103 (63.6%) had systemic comorbidities. No significant difference was observed when comparing demographics and comorbidities of NeuroCOVID patients presenting with and without fever and respiratory features. Moreover, no individual NeuroCOVID diagnosis was more prone to present with respiratory or febrile features. Diabetes mellitus was the only comorbidity which was significantly higher in the ischemic stroke group, all other comorbidities and characteristics were evenly distributed between stroke and non-stroke NeuroCOVID patients and encephalopathy non encephalopathy NeuroCOVID patients.
Stroke and encephalopathy are the most prevalent parainfectious neurological conditions occurring with COVID-19 in the Indian population. This study demonstrates seemingly low-risk individuals (i.e. people without pre-existing systemic and neurological comorbidities) may develop neurological conditions. Moreover, NeuroCOVID may manifest independent of respiratory features and fever.
描述加尔各答一家三级神经科中心收治的神经 COVID-19 患者的入院特征,加尔各答是印度东部最大和人口最多的大都市。
我们回顾性研究了 2020 年 5 月 1 日至 2021 年 1 月 30 日期间因神经系统疾病入院的确诊 COVID-19 患者。确定了此类患者的神经诊断及其与呼吸道特征的时间关系以及临床特征。
我们中心诊断了 228 例神经 COVID-19 患者。在纳入的 162 例患者中(中位年龄为 59(50-70)岁,62.3%(101 例)为男性),73.5%在出现任何呼吸道或发热症状之前被诊断为神经 COVID-19。46 例(28.8%)患者有预先存在的或合并的神经系统疾病,103 例(63.6%)有系统性合并症。在出现发热和呼吸道症状的神经 COVID-19 患者和无发热和呼吸道症状的患者之间,比较人口统计学特征和合并症没有发现显著差异。此外,没有任何一种神经 COVID-19 诊断更倾向于出现呼吸道或发热症状。糖尿病是缺血性卒中组中唯一显著更高的合并症,其他所有合并症和特征在卒中与非卒中神经 COVID-19 患者和神经 COVID-19 脑病与非脑病患者之间均匀分布。
在印度人群中,卒中和脑病是 COVID-19 最常见的感染后神经疾病。本研究表明,看似低风险的个体(即无预先存在的系统性和神经合并症的个体)可能会发生神经系统疾病。此外,神经 COVID-19 可能独立于呼吸道特征和发热表现。